Revance

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$3.67
Previous Close
$3.67
Day Range
$3.65-$3.68
52W Range
$2.30-$7.56
Market Cap
$383.1M
Shares Short
8M

Financials

See more
Revenue (12 Mos)
$256.9M
Revenue Growth (YoY)
10.7%
Gross Profit (12 Mos)
$103.6M
Diluted EPS
-$3.34

News

See more

Yahoo Finance • 22 hours ago

The Gross Law Firm Notifies Revance Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – RVNC

Yahoo Finance • 23 hours ago

Deadline Alert: Revance Therapeutics, Inc. (RVNC) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

Yahoo Finance • 2 days ago

RVNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Revance Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Yahoo Finance • 6 days ago

DEADLINE ALERT for RVNC, REGN, and BIOA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

About

CEO
Mr. Mark J. Foley
CFO
Mr. Tobin C. Schilke
Address
1222 Demonbreun Street, Nashville, TN, United States, 37203
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
597